Early‐onset and severe pulmonary arterial hypertension due to a novel compound heterozygous association of rare
<i>VHL</i>
mutations: A case report and review of existing data
release_h3gwy7oasjdvzkazucuycyewwq
by
LAURA CHOMETTE, Isabelle Migeotte, Céline Dewachter, Jean‐Luc Vachiery, Guillaume Smits, Antoine Bondue
Abstract
Very rare cases of pulmonary arterial hypertension (PAH) have been linked to homozygous or compound heterozygous von Hippel-Lindau (VHL) tumor suppressor gene mutations, while heterozygous VHL mutations lead to VHL tumor syndrome. Although those entities are defined, the genotype-phenotype correlation is incompletely understood, and patient management recommendations are lacking. Here, we describe a case of severe early-onset PAH due to a so-far unreported compound heterozygous association of VHL mutations and review the existing data.
In text/plain
format
Archived Files and Locations
application/pdf 213.5 kB
file_2pxbwmnsjzafbl74k3ztpowc3m
|
onlinelibrary.wiley.com (publisher) web.archive.org (webarchive) |
Read Archived PDF
Preserved and Accessible
Work Entity
access all versions, variants, and formats of this works (eg, pre-prints)
access all versions, variants, and formats of this works (eg, pre-prints)
Cite This
Lookup Links
oaDOI/unpaywall (OA fulltext)
Crossref Metadata (via API)
Worldcat
SHERPA/RoMEO (journal policies)
wikidata.org
CORE.ac.uk
Semantic Scholar
Google Scholar
Crossref Metadata (via API)
Worldcat
SHERPA/RoMEO (journal policies)
wikidata.org
CORE.ac.uk
Semantic Scholar
Google Scholar